ArticleCureus2024

Real-World Clinical Outcomes of Treatment With Olaparib for BRCA1/2 Mutation-Positive Metastatic Breast Cancer in Japanese Patients.

Kenichiro Tanaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.